These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2862984)

  • 1. Tardive dyskinesia: developmental factors.
    Yassa R; Ghadirian AM; Schwartz G
    Can J Psychiatry; 1985 Aug; 30(5):344-7. PubMed ID: 2862984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia and psychotropic drug history.
    Simpson GM; Varga E; Lee JH; Zoubok B
    Psychopharmacology (Berl); 1978 Jul; 58(2):117-24. PubMed ID: 28544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia and anticholinergic drugs.
    Gardos G; Cole JO
    Am J Psychiatry; 1983 Feb; 140(2):200-2. PubMed ID: 6129809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent tardive dyskinesia: demographic and pharmacological risk factors.
    Muscettola G; Pampallona S; Barbato G; Casiello M; Bollini P
    Acta Psychiatr Scand; 1993 Jan; 87(1):29-36. PubMed ID: 8093821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus late onset psychosis and tardive dyskinesia.
    Yassa R; Nair V; Schwartz G
    Biol Psychiatry; 1986 Nov; 21(13):1291-7. PubMed ID: 2875744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia: a review.
    Latimer PR
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S49-54. PubMed ID: 8564917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia in the aged. Duration of treatment relationships.
    Toenniessen LM; Casey DE; McFarland BH
    Arch Gen Psychiatry; 1985 Mar; 42(3):278-84. PubMed ID: 2858189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of psychotropic drug use and tardive dyskinesia.
    Branchey M; Branchey L
    J Clin Psychopharmacol; 1984 Feb; 4(1):41-5. PubMed ID: 6141189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors in the development of severe forms of tardive dyskinesia.
    Yassa R; Nair NP; Iskander H; Schwartz G
    Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drugs and tardive dyskinesia: preliminary results in an adolescent psychiatric ward.
    Dorevitch A; Meretyk I; Umansky Y; Galili-Weisstub E
    J Clin Pharm Ther; 1995 Apr; 20(2):63-5. PubMed ID: 7650076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia.
    Elliott KJ; Lewis S; el-Mallakh RS; Looney SW; Caudill R; Bacani-Oropilla T
    Ann Clin Psychiatry; 1994 Sep; 6(3):197-203. PubMed ID: 7881501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amisulpride-induced tardive dyskinesia.
    Fountoulakis KN; Panagiotidis P; Siamouli M; Kantartzis S; Mavridis T; Iacovides A; Kaprinis G
    Schizophr Res; 2006 Dec; 88(1-3):232-4. PubMed ID: 16963229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescents on neuroleptic medication: is this population at risk for tardive dyskinesia?
    McDermid SA; Hood J; Bockus S; D'Alessandro E
    Can J Psychiatry; 1998 Aug; 43(6):629-31. PubMed ID: 9729692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up study of 11 patients with potentially reversible tardive dyskinesia.
    Yagi G; Itoh H
    Am J Psychiatry; 1987 Nov; 144(11):1496-8. PubMed ID: 2890309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia in elderly psychiatric patients: a 5-year study.
    Yassa R; Nastase C; Dupont D; Thibeau M
    Am J Psychiatry; 1992 Sep; 149(9):1206-11. PubMed ID: 1354413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.